S2 Part 1: Processing and minor processing

Published Date: 16 Feb 2023

Dr. Jacob Sands and Dr. Jared Weiss talk about subtypes. ongoing clinical trials; sustained sustained response to treatment; And it is possible to use the word "cure" to treat a small breast cancer.

Read Full News

Latest News

Optimizing DPYD Testing Prior to Fluoropyrimidine Therapy

A PDSA-driven QI project cut DPYD testing turnaround from 16.7 to 12.7 days, though "expedite" order comments alone showed little added benefit.

Syngeneic Modeling of Diet-Driven Liver Cancer

New mouse model of MASLD-driven liver cancer shows sex-based tumor onset and responds to FOG-001, a first-in-class Wnt/β-catenin inhibitor.

VA Dashboards for Clinical Pathway & Genetic Testing Use

New VA dashboards tracking Clinical Pathway adherence helped raise lung cancer testing documentation from 57% to 76% and treatment templates to 42%.

Melanoma Clinical Pearls: 5 Core Principles

Are you up to date on excision margins, sentinel node candidacy, and hereditary risk? Review five critical clinical nuances to refine your approach to melanoma care.

Q&A: Melanoma Clinical Guidance

Do you know the current guidelines for suspicious lesion workups, pathology drivers, and targeted imaging? Explore key diagnostic and management questions shaping modern melanoma care.

Woman’s 3-Year Lip Swelling Reveals Granulomatous Cheilitis

A chronic, painless lip swelling proved diagnostically challenging until histology showed epithelioid granulomas and excluded infection and sarcoidosis.

Todays Updates

Transforming Perioperative MIBC Care in Community Practice: Navigating Emerging Data, Guideline Changes, and Adverse Event Management Protocols

Transforming Perioperative MIBC Care in Community Practice: Navigating Emerging Data, Guideline Changes, and Adverse Event Management Protocols

Doctors Remain Trusted Sources for Cancer Info in Post-Pandemic Era

Not surprisingly, trust in government health agencies for cancer info has dipped

Groundbreaking Pancreatic Cancer Drug Shows Promise in Lung Cancer

Response rates with daraxonrasib ranged from 31% to 37% in previously treated RAS-mutant NSCLC

Blood Cancer's First New Drug in 29 Years; AI for Mammography? Phase III Myeloma Win

News, features, and commentary about cancer-related issues

More Evidence Ties Microplastics to Lung Cancer

Observational study shows greater microplastic burden in patients with lung malignancy

Nationwide Epinephrine Recall; FBI's Fauci Probe; Bruce Campbell's Cancer

Health news and commentary gathered by MedPage Today staff

9/11's Latest Wave of Cancers, 25 Years On

The health ramifications of the attack persist

Todays Updates

Transforming Perioperative MIBC Care in Community Practice: Navigating Emerging Data, Guideline Changes, and Adverse Event Management Protocols

Transforming Perioperative MIBC Care in Community Practice: Navigating Emerging Data, Guideline Changes, and Adverse Event Management Protocols

Doctors Remain Trusted Sources for Cancer Info in Post-Pandemic Era

Not surprisingly, trust in government health agencies for cancer info has dipped

Groundbreaking Pancreatic Cancer Drug Shows Promise in Lung Cancer

Response rates with daraxonrasib ranged from 31% to 37% in previously treated RAS-mutant NSCLC

Blood Cancer's First New Drug in 29 Years; AI for Mammography? Phase III Myeloma Win

News, features, and commentary about cancer-related issues

More Evidence Ties Microplastics to Lung Cancer

Observational study shows greater microplastic burden in patients with lung malignancy

Nationwide Epinephrine Recall; FBI's Fauci Probe; Bruce Campbell's Cancer

Health news and commentary gathered by MedPage Today staff

9/11's Latest Wave of Cancers, 25 Years On

The health ramifications of the attack persist

Latest News

A PDSA-driven QI project cut DPYD testing turnaround from 16.7 to 12.7 days, though "expedite" order comments alone showed little added benefit.

New mouse model of MASLD-driven liver cancer shows sex-based tumor onset and responds to FOG-001, a first-in-class Wnt/β-catenin inhibitor.

New VA dashboards tracking Clinical Pathway adherence helped raise lung cancer testing documentation from 57% to 76% and treatment templates to 42%.

Are you up to date on excision margins, sentinel node candidacy, and hereditary risk? Review five critical clinical nuances to refine your approach to melanoma care.

Do you know the current guidelines for suspicious lesion workups, pathology drivers, and targeted imaging? Explore key diagnostic and management questions shaping modern melanoma care.

A chronic, painless lip swelling proved diagnostically challenging until histology showed epithelioid granulomas and excluded infection and sarcoidosis.

News All Time

A Woman on Ruxolitinib Had TB That Mimicked Metastases

A woman receiving ruxolitinib for polycythemia vera developed disseminated tuberculosis despite a negative IGRA, highlighting the limits of screening.

Pediatric Gastroenterology Faces AI Reality Check

From nutrition screening to IBD monitoring, AI shows promise in pediatric gastroenterology — yet experts stress pediatric validation is essential.

Hidradenitis Suppurativa–Associated Squamous Cell Carcinoma

Four cases highlight the aggressive nature of cutaneous squamous cell carcinoma arising in chronic perianal and gluteal hidradenitis suppurativa.

FDA Neurology Digest: August 2026

A monthly snapshot of FDA activity involving therapies used in the prevention, diagnosis, and treatment of neurologic conditions.

Sentinel Lymph Node Biopsy De-Implementation in Women Veterans

This study sought to quantify low-value sentinel lymph node biopsy practices among populations eligible for a de-escalated surgical approach in VA.

Expanding Access to Pediatric Dermatology Through Store-and-Forward Teledermatology

A pediatric dermatology–specific store-and-forward service can enhance access to specialty expertise, support care coordination, and integrate into clinical practice without increasing consultant workload.

Informed-Consent Gaps in Prostate Cancer Genetic Testing

Are oncologists missing key details during genetic testing consent? Dr Maurie Markman reviews new data and why current informed consent falls short.

Kratom: An Emerging Cause of Drug-Induced Hyperpigmentation

Kratom is an increasingly common environmental exposure with potential dermatologic consequences. Learn to recognize its association with hyperpigmentation.

Rethinking Laboratory Screening for Patients Receiving Biologics

Do all patients on biologics need routine laboratory screening? A risk-based approach can help clinicians determine when testing is truly worthwhile.

CCND1-Negative Mantle Cell Lymphoma With Balanced CCND3-IGH Rearrangement: Case Report and Literature Review

CCND1-Negative Mantle Cell Lymphoma With Balanced CCND3-IGH Rearrangement: Case Report and Literature Review

Development of a National Hematology Program: Advancing Classical Hematology Care for Veterans

Many classical (nonmalignant) hematologic disorders—including venous thromboembolism (VTE), sickle cell trait, bleeding or clotting disorders, G6PD deficiency, and others—have a propensity to manifest under physical stress or trauma.

Solitary Tender Nodule on the Forearm

A 36-year-old woman presented to the dermatology department with a nodule on the left forearm. What’s your diagnosis?

S1 Episode 4: How Early Is Early Enough to Reverse MASLD?

Drs VanWagner and Chen discuss whether fatty liver is reversible, weight-loss targets, diet quality, exercise, and where GLP-1s and bariatric surgery fit into MASLD treatment.

Teen With a Slowly Enlarging Annular Hyperkeratotic Papule

The lesion initially appeared as a small papule and gradually enlarged, with more noticeable growth in recent months. The lesion was not painful, pruritic, or bleeding.

ArteraAI: Current Indications in Prostate Cancer

From localized disease to recurrence, where can ArteraAI add actionable insight for patients with prostate cancer?

Thyroid Surgery: Practical Strategies for Optimal Post-op Care

Drs Kaniksha Desai and Michael Yeh discuss practical aspects of postoperative thyroid surgery care.

Recommended News For You

Enhanced access for patients with prostate cancer is provided by the new SPECT/CT technique, which demonstrates remarkable biomarker identification.

ASCO: Vepdegestrant ups survival in ER+, HER2− advanced breast cancer with ESR1 mutations

Will a Mindfulness-Based Treatment for Depression Increase Recovery Rates?

Severe obesity associated with reduced prevalence of recommended cancer screenings

The First Gene Therapy Provides a Durable Response for Non-Muscle-Invasive Bladder Cancer.

Omitting Biopsy After Negative MRI Halves Diagnoses of Insignificant Prostate Cancer

Survivors of high-risk neuroblastoma face substantial late effects of modern therapies

Recommended Articles For You

Unlocking the Secrets of Oral Cancer Staging: A New Approach to Early Detection 

Polyposis Syndrome: Causes, Symptoms, and Treatment Options 

Rehabilitation After Function-Preserving Oncologic Reconstruction 

Predicting Incidental Prostate Cancer in BPH Surgery Patients 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Increased anti-tumor response and reduced side effects from immune checkpoint inhibitors.

2.

For cancer patients who are not responding to chemotherapy, new genes and natural toxins offer hope.

3.

Oncology Drug Shortages Persist, but Continue to Evolve

4.

Is Exercise an Effective Treatment for Prostate Cancer?

5.

Asymptomatic Brain Metastases in EGFR-Mutant NSCLC

1.

Patient Management for Bone Marrow Functional Reserve Maintenance

2.

Understanding Carcinoid Tumors: Diagnosis, Symptoms, and Treatment Options 

3.

Emerging Dysregulated Signaling Pathways in Early-Onset Colorectal Cancer

4.

From Bench to Bedside: The New Era of Lymphoma Treatment and Education

5.

New Anticoagulants: Balancing Efficacy and Safety in Patients with Atrial Fibrillation

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II

2.

Understanding the Common Causes of Anemia

3.

Preventing Blood Clots: The Importance of Venous Thromboembolism Management

4.

Recognizing General Warning Signs of Cancer

5.

The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot